Chromothripsis events on chromosomes 2, 5, and 17 in neuroblastoma tumors have been previously reported to be associated with MYCN amplification, TERT rearrangements, and 17q gain, respectively (Molenaar et al., 2012; Boeva et al., 2013). This evidence concerns the gene MYCN and neuroblastoma.